The Most Confounding Affliction: Tom Zeller Jr. on Headache Disorders, Stigma & the Science Gap
- Katie Slay
- 3 days ago
- 6 min read
Welcome to Chronically Peachy, a podcast co-hosted by Sophia Fang, founder of Peachy Day, and Bernadette of @ChronicAccounts. This space exists for honest conversations that keep it real and peachy about living alongside migraine.
We share unfiltered stories, break down migraine hot topics, and uplift community conversations with neurologists, experts, and advocates. If you're looking for validation, accessible info, or just two friends who genuinely get it, you're in the right place!
About This Episode
In this episode, Bernadette and Sophia sit down with Tom Zeller Jr., award-winning journalist, former New York Times reporter, and author of The Headache: The Science of a Most Confounding Affliction and A Search for Relief. Tom has lived with cluster headache for decades and has become one of the most prominent voices writing about headache disorders publicly.
Part memoir, part scientific investigation, his book weaves together history, neuroscience, and patient stories to examine one of the most widespread yet misunderstood forms of pain. This conversation covers what cluster headache actually feels like, why stigma runs deeper than most people realize, where the scientific research currently stands, and what gives Tom hope for the headache community.
What is cluster headache, and how is it different from migraine?
Cluster headache affects less than 1% of the population, making it significantly rarer than migraine. Tom describes the pain as among the most intense a human being can experience, comparable to holding your hand on a hot burner and being unable to pull it away.
Unlike migraine, cluster attacks tend to ramp up to peak intensity within minutes and with little to no warning. A single attack typically lasts anywhere from 15 minutes to three hours before disappearing as quickly as it came. Along with the head pain, attacks are almost always accompanied by autonomic symptoms on the same side, like a drooping eyelid, red or tearing eye, and a runny nose. The attacks often cluster in cycles and can occur multiple times a day during an active period.
Because of the rarity, many people, including doctors, have never encountered it. That invisibility compounds the isolation people with cluster headaches already experience.
Why is it so hard to describe head pain?
Tom has spent decades as a journalist finding words for difficult subjects, and he's direct about this one: pain may be the most subjective experience there is. There is no objective measure for it. The 1-to-10 cartoon face scale on a doctor's office wall doesn't come close to capturing what patients are actually experiencing.
What fills that gap is trust, and that trust is frequently broken. Patients have to convince providers their pain is real. Providers have to choose to believe them. When either side falters, the result is a person suffering alone, often in silence, often for years.
Tom's response to that gap, both in the book and in this conversation: the only way through it is to keep talking, keep explaining, and resist the impulse to hide, even when hiding feels safer.
What is the real cost of not treating headache disorders?
For most of his career, Tom hid his cluster headache completely. In newsrooms, during attacks, he'd find somewhere to disappear and ride it out. He never named it. He never asked for accommodation. He managed everything in secret.
He's now clear that this kind of hiding, while understandable, contributes to the stigma itself. When a condition is invisible not just neurologically but socially, when the people who have it work hard to make sure no one knows, it becomes easier for the culture to dismiss it.
Writing the book required him to do the opposite. His editor pushed him to stop being a reporter at a distance and actually show up in the story. He describes the process as getting naked, a level of honesty that went against everything his journalism training had taught him. Once he got there, the book found its voice.
How deep does migraine and headache stigma actually go?
Deeper than most people realize, including Tom before he started researching.
Across interviews with clinicians and researchers in the US, Denmark, and Asia, Tom heard the same thing repeatedly: people were actively discouraged from specializing in headache medicine by their own mentors. The message was consistent, headache isn't real neurology, it's not serious enough, there are better things to study.
Research from the University of Michigan has documented that headache disorders generate a measurable and disproportionate level of judgment and even disgust in people, a response that doesn't match the actual severity of the conditions. Tom believes the roots are linguistic, cultural, and significantly misogynistic, noting that the shift away from treating headache as a serious medical pursuit tracks closely with the rise of Freudian frameworks that blamed the patient's personality.
Why migraine and cluster headache are neurobiological disorders, not vascular ones
Most people, if asked what causes a headache, would still describe blood vessels swelling and pressing on nerves. That model dominated medicine for a long time.
Current research points to the brain, specifically the hypothalamus and the autonomic nervous system, as the central driver. The hypothalamus activates and sets off a cascade of physiological events that, in people with headache disorders, results in pain. The vascular changes are real, but they appear to be a downstream effect rather than the cause.
This matters clinically because the old vascular model gave patients and doctors an easy but wrong explanation: just relax, reduce stress, and the blood flow will normalize. The neurobiological model makes clear that headache disorders are brain disorders with genetic and neurochemical roots, not lifestyle failures.
Where do migraine patients still fall through the gaps in science?
Tom's answer is direct: the average primary care physician, usually the first point of contact for most headache patients, receives only 1-2 hours of migraine training in medical school and works from outdated frameworks of care.
In Montana, where Tom now lives, there is only one headache specialist in the entire state. That is not unusual. Most people with migraine or other headache disorders will never see a specialist at all. They will be told by primary care to try aspirin, reduce stress, and come back if it gets worse.
Closing that gap requires educating primary care physicians, not just headache specialists. The specialists who exist can't absorb the volume of patients who need them.
Why CGRP medications changed everything for migraine treatment
The approval of CGRP medications starting in 2018 was significant not just clinically but culturally. It demonstrated that investing in headache research could produce real results, shifting the perception of migraine from an untreatable condition to one where meaningful intervention is possible.
Tom is cautious about what happens next. Sumatriptan came to market in the early 1990s and it took nearly 30 years before the next major class of migraine treatments arrived. If nothing meaningful follows CGRP within the next several years, he worries the funding momentum will stall again.
Other areas currently attracting research attention include PACAP and VIP, two neuropeptides that appear to play roles in triggering attacks, and ion channel research being done in Denmark. These are early-stage but promising signals.
What gives Tom hope about the headache community
The conversations themselves have shifted. Advocates are building public platforms, researchers are starting to be heard, and the success of CGRP treatments has demonstrated proof of concept for the broader medical and funding community.
He's also encouraged by researchers like Peter Goadsby who came to headache medicine without a personal connection to the condition and simply found it fascinating, a sign that the field can attract scientists on intellectual merit alone, not just personal necessity.
His message to anyone sitting on the fence about whether to seek help, speak up, or just keep hiding: the cost of continued silence is real. The community that exists on the other side of that silence is worth finding.
Migraine care shouldn’t feel like a full-time job.
If you’re living with migraine, you deserve more than guesswork and rushed appointments.
Peachy Day is a migraine prevention app, designed to lighten your load. You can:
Log in 1 minute a day, even during attacks
Get personalized health insights on a color-coded calendar
Make the most of your doctor’s visits
Get migraine predictions to prevent future attacks
Build confidence in how you understand and talk about migraine
Our team brings together 125+ years of experience as migraine patients and 50+ years as headache neurologists, including the founder of Stanford and USC’s Headache Clinic.
Download Peachy Day for free on the App Store or Google Play. 🍑



